Literature DB >> 17260063

Is posttraumatic epilepsy the best model of posttraumatic epilepsy?

Andrey Mazarati.   

Abstract

Entities:  

Year:  2006        PMID: 17260063      PMCID: PMC1783489          DOI: 10.1111/j.1535-7511.2006.00149.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  6 in total

Review 1.  Post-traumatic epilepsy: cellular mechanisms and implications for treatment.

Authors:  L J Willmore
Journal:  Epilepsia       Date:  1990       Impact factor: 5.864

2.  Brain injury-induced enhanced limbic epileptogenesis: anatomical and physiological parallels to an animal model of temporal lobe epilepsy.

Authors:  D A Coulter; A Rafiq; M Shumate; Q Z Gong; R J DeLorenzo; B G Lyeth
Journal:  Epilepsy Res       Date:  1996-12       Impact factor: 3.045

3.  Progression from frontal-parietal to mesial-temporal epilepsy after fluid percussion injury in the rat.

Authors:  Raimondo D'Ambrosio; Jason S Fender; Jared P Fairbanks; Ednea A Simon; Donald E Born; Dana L Doyle; John W Miller
Journal:  Brain       Date:  2004-11-24       Impact factor: 13.501

4.  Long-term hyperexcitability in the hippocampus after experimental head trauma.

Authors:  V Santhakumar; A D Ratzliff; J Jeng; Z Toth; I Soltesz
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

5.  A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats.

Authors:  I Kharatishvili; J P Nissinen; T K McIntosh; A Pitkänen
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

6.  Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus.

Authors:  D H Lowenstein; M J Thomas; D H Smith; T K McIntosh
Journal:  J Neurosci       Date:  1992-12       Impact factor: 6.167

  6 in total
  1 in total

Review 1.  Endocannabinoids: A Promising Impact for Traumatic Brain Injury.

Authors:  Lesley D Schurman; Aron H Lichtman
Journal:  Front Pharmacol       Date:  2017-02-17       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.